Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Liabilities and Shareholders Equity (2023 - 2025)

Fractyl Health (GUTS) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $114.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity fell 9.97% year-over-year to $114.3 million, compared with a TTM value of $367.4 million through Sep 2025, down 28.4%, and an annual FY2024 reading of $108.1 million, up 41.81% over the prior year.
  • Liabilities and Shareholders Equity was $114.3 million for Q3 2025 at Fractyl Health, up from $62.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $163.5 million in Q1 2024 and bottomed at $62.0 million in Q2 2025.
  • Average Liabilities and Shareholders Equity over 3 years is $110.1 million, with a median of $111.2 million recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity soared 41.81% in 2024, then tumbled 57.66% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $76.2 million in 2023, then skyrocketed by 41.81% to $108.1 million in 2024, then grew by 5.73% to $114.3 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for GUTS at $114.3 million in Q3 2025, $62.0 million in Q2 2025, and $83.0 million in Q1 2025.